These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20734572)

  • 1. Characterization of an ambulatory population with stable coronary artery disease and importance of heart rate: the PULSAR registry.
    Seabra-Gomes R;
    Rev Port Cardiol; 2010 Apr; 29(4):483-508. PubMed ID: 20734572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
    Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
    Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
    Tendera M; Fox K; Ferrari R; Ford I; Greenlaw N; Abergel H; Macarie C; Tardif JC; Vardas P; Zamorano J; Gabriel Steg P;
    Int J Cardiol; 2014 Sep; 176(1):119-24. PubMed ID: 25042656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
    Diaz A; Bourassa MG; Guertin MC; Tardif JC
    Eur Heart J; 2005 May; 26(10):967-74. PubMed ID: 15774493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry.
    Stępińska J; Marona M; Greenlaw N; Steg G;
    Kardiol Pol; 2014; 72(11):1156-64. PubMed ID: 25001472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadequate control of heart rate in patients with stable angina: results from the European heart survey.
    Daly CA; Clemens F; Sendon JL; Tavazzi L; Boersma E; Danchin N; Delahaye F; Gitt A; Julian D; Mulcahy D; Ruzyllo W; Thygesen K; Verheugt F; Fox KM;
    Postgrad Med J; 2010 Apr; 86(1014):212-7. PubMed ID: 20354044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of an anesthesia information system to identify and trend gender disparities in outpatient medical management of patients with coronary artery disease.
    Vigoda MM; Rodríguez LI; Wu E; Perry K; Duncan R; Birnbach DJ; Lubarsky DA
    Anesth Analg; 2008 Jul; 107(1):185-92. PubMed ID: 18635487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W; Wilkins A; Pociupany R; Ponikowski P
    Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of patients with coronary artery disease managed on an outpatient basis in the population of Poland. Results of the multicentre RECENT trial.
    Banasiak W; Pociupany R; Wilkins A; Ponikowski P
    Kardiol Pol; 2007 Feb; 65(2):132-40; discussion 141-2. PubMed ID: 17366357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate as a treatable cardiovascular risk factor.
    Tardif JC
    Br Med Bull; 2009; 90():71-84. PubMed ID: 19474056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
    Fox K; Ford I; Steg PG; Tendera M; Robertson M; Ferrari R;
    Eur Heart J; 2009 Oct; 30(19):2337-45. PubMed ID: 19720635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate and pulse pressure at rest are major prognostic markers of early postoperative complications after coronary bypass surgery.
    Aboyans V; Frank M; Nubret K; Lacroix P; Laskar M
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):971-6. PubMed ID: 18396057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative beta-blocker use: impact of national guidelines on clinical practice.
    Akhtar S; Assaad S; Amin M; Holt NF; Barash PG; Silverman DG
    J Clin Anesth; 2008 Mar; 20(2):122-8. PubMed ID: 18410867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate and use of β-blockers in Mexican stable outpatients with coronary artery disease.
    Alcocer-Gamba MA; Martínez-Sánchez C; Verdejo-Paris J; Ferrari R; Fox K; Greenlaw N; Steg Philippe G;
    Arch Cardiol Mex; 2015; 85(4):270-7. PubMed ID: 25921309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.